UK IBD REGISTRY ENDS YEAR ON A HIGH NOTE

We reached the end of 2016 with 60 sites actively participating in the IBD Registry, and over 21,000 patient records submitted. 80 sites in total have a ‘live’ system for data capture, and 21 additional sites are in the process of setting up so we expect patient numbers to increase steadily. If you have not yet registered to participate in the IBD Registry, would like help uploading your data, or have any other registry related queries please contact support@ibdregistry.org.uk

DID YOU KNOW?

  • The RCP audit is closing in January 2017
  • The IBD Registry is now the vehicle for the biologics audit and quality improvement programme
  • Biologics audit data can be transferred from the RCP audit into the IBD Registry Web Tool or PMS before the audit closes in mid-JanuaryFor more information please contact IBDProgramme@rcplondon.ac.uk
  • As part of the transition, we encourage teams to attend 10 years of the UK IBD audit: framing the future at the RCP in London on Friday 3 February 2017. Click here to book your free ticket.

BE PART OF THE REGISTRY PUBLICATION COLLECTIVE

Looking ahead to 2017, we’re aiming to present the first IBD Registry data on Wednesday 21 June 16:30 – 18:00 at the BSG annual meeting, with a publication reporting on the majority of biologics patients in England at the end of the year. All sites contributing patient records will be acknowledged in presentations of Registry data. Details will be available in the new year.

FUNDING AVAILABLE FOR LOCAL DATA ENTRY SUPPORT

The Registry has set up an industry working group with a number of pharma companies; as well as working to secure significant funding for long term maintenance of the registry, members of the industry group have generously contributed to a fund specifically to help sites with data entry. Many thanks to our colleagues at AbbVie, Allergan, Dr Falk, Janssen, Napp, Pfizer, Takeda, Tillotts and Vifor for their contributions to this fund. For more information please contact support@ibdregistry.org.uk by 20th January.

DID YOU KNOW?

  • Teams can participate in the IBD Registry using their own choice of data entry systems to suit local needs (including some existing local systems)
  • Being part of the IBD Registry will give teams:
    • Robust local data to manage their biologics patients and IBD service more effectively, efficiently and safely
    • Evidence to benchmark the quality of their service as part of a nation al audit of the safety and appropriate use of biologics
  • For more information on the IBD Registry, visit ibdregistry.org.uk

WHAT NEXT?

If you’ve registered to join the IBD Registry you will have information about what you need to do to participate. If you haven’t already done so, please register to be part of the programme using this form. For any other queries please contact support@ibdregistry.org.uk

With our thanks to you for your continued contribution to the IBD Registry,

Dr Stuart Bloom, IBD Registry Chair


Dr Fraser Cummings, IBD Registry Clinical Lead

KEY DATES:

  • 13 January 2017: RCP audit closes (audit data will not be accessible after this date)
  • 20 January 2017: Deadline for applications for local data entry support funding
  • 3 February 2017: 10 years of the UK IBD audit: framing the future, RCP in London
  • April / May 2017: IBD Registry Roadshow (dates and venues will be circulated soon)
  • 19-22 June 2017: BSG Annual Meeting 2017, Manchester
  • December 2017: Publication of the IBD Registry initial report

Save

Find out more about…

Latest News

We are hiring – three systems and data science roles

The IBD Registry is a small, fast-moving and innovative organisation working in the world of healthcare data to provide insights and solutions that benefit people with inflammatory bowel disease (IBD). We are looking for three systems and data science professionals to...

read more

COVID-19 IBD Risk Tool wins award

We were thrilled to win an award at the  Communique Awards for our work in creating and communicating our COVID-19 IBD Risk Tool for people with inflammatory bowel disease (IBD). The 2021 Communique Awards took place on 1 September and recognise excellence and best...

read more

2021 Annual Report on Biological Therapies in IBD

Clinical teams providing biological therapies for people with inflammatory bowel disease (IBD) are maintaining good practices of care despite increased pressures from COVID-19, according to the latest report from the IBD Registry. The second annual report on the use...

read more

Reflections in our birthday month

Unbelievably, it’s now 3 years since we set up IBD Registry Ltd as an independent not-for-profit organisation, following the original launch by the British Society of Gastroenterology (BSG) in June 2013. A birthday is a good time for reflection. We're owned and...

read more

Partnering for PINPOINT

The PINPOINT study (the Prospective Incidence of Paediatric-Onset Inflammatory bowel disease in the United Kingdom) is undertaking a UK-wide incidence study of paediatric IBD. The number of children newly diagnosed with inflammatory bowel disease (IBD) each year has...

read more
%d bloggers like this: